Address

GIMV NV
37 Karel Oomstraat
2018 Antwerpen
Belgium

Open map


Recent investment activity

KANDO id: 713

Corporate information

Also known as
Gewestelijke Investeringsmaatschappij voor Vlaanderen
Registration country

Funding rounds

Investment preferences

Focus countries
France
Investment focus themes
Top investment portfolio themes


Investment activity status
Active investor

Selected investments

Displaying 1 - 22 of 22
Profile Country Date Funding
Ambit Biosciences Inc A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer. Series D
Ceres Inc Plant genomics biotechnology company N/A
ChemoCentryx Inc N/A
Ebuzzing SA Leading global platform for social video advertising. N/A USD 14,500,000 (USD 14,500,000)
Interwise Inc N/A
Nereus Pharmaceuticals Inc Series A
Nereus Pharmaceuticals Inc N/A
Nereus Pharmaceuticals Inc Series D
Neurotech Pharmaceuticals Inc (Neurotech Inc) Cell-based drugs for diseases of the eye. N/A
Plexxikon Inc N/A
Proficient Systems Inc Enterprise software company. N/A
Prosensa N/A
Santhera Pharmaceuticals AG Small molecule therapeutics for neuromuscular and metabolic diseases. IPO in November 2006. N/A
Ubidyne Inc Developer of an antenna embedded digital radio tech. Series B
Xanthus Pharmaceuticals Inc N/A
CoreOptics GmbH N/A
Coreoptics Inc Venture
General Fusion Inc General Fusion is developing fusion technology to generate affordable, safe and plentiful energy. Series E
GOVECS Venture Led the round.
McPhy Venture
PowerInbox Inc Series A
Seedcamp Investments LLP Early stage mentoring and investment programme for European startups. N/A

Current team

Financials